{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T18:22:06Z","timestamp":1788373326011,"version":"build-2803163510"},"reference-count":83,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T00:00:00Z","timestamp":1705276800000},"content-version":"am","delay-in-days":348,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.nmd.2022.12.001","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T13:26:08Z","timestamp":1670246768000},"page":"169-182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Myositis with prominent B cell aggregates may meet classification criteria for sporadic inclusion body myositis"],"prefix":"10.1016","volume":"33","author":[{"given":"Alain","family":"Meyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Troyanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pat","family":"Korathanakhun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oc\u00e9ane","family":"Landon-Cardinal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Leclair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hughes","family":"Allard-Chamard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josiane","family":"Bourr\u00e9-Tessier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Makhzoum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Isabelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Larue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Grand'Maison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami","family":"Massie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu Le","family":"Page","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Routhier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farah","family":"Zarka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavie","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Sonnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marvin","family":"Fritzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Sen\u00e9cal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Karamchandani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Ellezam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"O'Ferrall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2022.12.001_bib0001","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/nan.12380","article-title":"Integrated classification of inflammatory myopathies","volume":"43","author":"Allenbach","year":"2017","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"12","key":"10.1016\/j.nmd.2022.12.001_bib0002","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1001\/jamaneurol.2018.2598","article-title":"Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies","volume":"75","author":"Mariampillai","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.nmd.2022.12.001_bib0003","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/WCO.0000000000000855","article-title":"Where are we moving in the classification of idiopathic inflammatory myopathies?","volume":"33","author":"Tanboon","year":"2020","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.nmd.2022.12.001_bib0004","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0046-8177(86)80180-0","article-title":"Mononuclear cells in myopathies: quantitation of functionally distinct subsets, recognition of antigen-specific cell-mediated cytotoxicity in some diseases, and implications for the pathogenesis of the different inflammatory myopathies","volume":"17","author":"Engel","year":"1986","journal-title":"Hum Pathol"},{"key":"10.1016\/j.nmd.2022.12.001_bib0005","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1001\/archneur.1981.00510120077014","article-title":"Polymyositis with infiltration by lymphoid follicles","volume":"38","author":"Mashaly","year":"1981","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nmd.2022.12.001_bib0006","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0960-8966(96)00015-6","article-title":"Peripheral lymphoid tissue-like adhesion molecule expression in nodular infiltrates in inflammatory myopathies","volume":"6","author":"De Bleecker","year":"1996","journal-title":"Neuromuscul Disord NMD"},{"key":"10.1016\/j.nmd.2022.12.001_bib0007","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/art.21822","article-title":"Brachio-cervical inflammatory myopathies: clinical, immune, and myopathologic features","volume":"54","author":"Pestronk","year":"2006","journal-title":"Arthritis Rheum. Arthritis Rheum."},{"key":"10.1016\/j.nmd.2022.12.001_bib0008","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/jnen\/nlab071","article-title":"Pathology features of immune and inflammatory myopathies, including a polymyositis pattern, relate strongly to serum autoantibodies","volume":"80","author":"Pestronk","year":"2021","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.nmd.2022.12.001_bib0009","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/BOR.0b013e32834bab42","article-title":"Acquired immune and inflammatory myopathies: pathologic classification","volume":"23","author":"Pestronk","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.nmd.2022.12.001_bib0010","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ana.410160206","article-title":"Monoclonal antibody analysis of mononuclear cells in myopathies. I: quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells","volume":"16","author":"Arahata","year":"1984","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2022.12.001_bib0011","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/BOR.0000000000000831","article-title":"Lymphocyte immunophenotyping in inflammatory myositis: a review","volume":"33","author":"Franco","year":"2021","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.nmd.2022.12.001_bib0012","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1212\/01.wnl.0000187124.92826.20","article-title":"Plasma cells in muscle in inclusion body myositis and polymyositis","volume":"65","author":"Greenberg","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2022.12.001_bib0013","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.nmd.2019.10.005","article-title":"ENMC 239th workshop study group. 239th ENMC international workshop: classification of dermatomyositis, Amsterdam, the Netherlands, 14-16 December 2018","volume":"30","author":"Mammen","year":"2020","journal-title":"Neuromuscul Disord NMD"},{"key":"10.1016\/j.nmd.2022.12.001_bib0014","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1001\/jamaneurol.2020.0673","article-title":"Association of dermatomyositis sine dermatitis with anti-nuclear matrix protein 2 autoantibodies","volume":"77","author":"Inoue","year":"2020","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.nmd.2022.12.001_bib0015","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.nmd.2014.12.001","article-title":"205th ENMC International Workshop: Pathology diagnosis of idiopathic inflammatory myopathies part II 28-30 March 2014, Naarden, The Netherlands","volume":"25","author":"De Bleecker","year":"2015","journal-title":"Neuromuscul Disord NMD"},{"key":"10.1016\/j.nmd.2022.12.001_bib0016","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00401-021-02335-x","article-title":"Landon-Cardinal O. Capillary basement membrane reduplication in myositis patients with mild clinical features of systemic sclerosis supports the concept of \u201cscleromyositis","volume":"142","author":"Ellezam","year":"2021","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.nmd.2022.12.001_bib0017","first-page":"1784","article-title":"Autoantibodies to a novel Rpp38 (Th\/To) derived B-cell epitope are specific for systemic sclerosis and associate with a distinct clinical phenotype","volume":"58","author":"Koenig","year":"2019","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.nmd.2022.12.001_bib0018","doi-asserted-by":"crossref","first-page":"745","DOI":"10.3389\/fimmu.2019.00745","article-title":"Anti-NT5c1A Autoantibodies as Biomarkers in Inclusion Body Myositis","volume":"10","author":"Amlani","year":"2019","journal-title":"Front Immunol."},{"key":"10.1016\/j.nmd.2022.12.001_bib0019","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2020-001357","article-title":"Recognising the spectrum of scleromyositis: HEp-2 ANA patterns allow identification of a novel clinical subset with anti-SMN autoantibodies","volume":"6","author":"Landon-Cardinal","year":"2020","journal-title":"RMD Open"},{"key":"10.1016\/j.nmd.2022.12.001_bib0020","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1093\/rheumatology\/key451","article-title":"Combining immunofluorescence with immunoblot assay improves the specificity of autoantibody testing for myositis","volume":"58","author":"Infantino","year":"2019","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.nmd.2022.12.001_bib0021","article-title":"The reliability of immunoassays to detect autoantibodies in patients with myositis is dependent on autoantibody specificity","volume":"10","author":"Tansley","year":"2020","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.nmd.2022.12.001_bib0022","article-title":"Concordance between myositis autoantibodies and anti-nuclear antibody patterns in a real-world","volume":"keac039","author":"He","year":"2022","journal-title":"Australian cohort. Rheumatol Oxf Engl."},{"key":"10.1016\/j.nmd.2022.12.001_bib0023","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","article-title":"119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands","volume":"14","author":"Hoogendijk","year":"2004","journal-title":"Neuromuscul Disord Neuromuscul Disord NMD"},{"key":"10.1016\/j.nmd.2022.12.001_bib0024","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/ana.410380504","article-title":"Inclusion body myositis and myopathies","volume":"38","author":"Griggs","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2022.12.001_bib0025","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1212\/WNL.61.3.316","article-title":"Polymyositis: an overdiagnosed entity","volume":"61","author":"van der Meulen","year":"2003","journal-title":"N Neurology"},{"key":"10.1016\/j.nmd.2022.12.001_bib0026","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"2017 European league against rheumatism\/American college of rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"76","author":"Lundberg","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.nmd.2022.12.001_bib0027","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.nmd.2009.11.003","article-title":"Inclusion body myositis: MRC centre for neuromuscular diseases, IBM workshop, London, 13 June 2008","volume":"20","author":"Hilton-Jones","year":"2010","journal-title":"Neuromuscul Disord NMD"},{"key":"10.1016\/j.nmd.2022.12.001_bib0028","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.nmd.2013.08.007","article-title":"188th ENMC international workshop: inclusion body myositis, 2-4 December 2011, Naarden, The Netherlands","volume":"23","author":"Rose","year":"2013","journal-title":"Neuromuscul Disord NMD"},{"key":"10.1016\/j.nmd.2022.12.001_bib0029","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1212\/WNL.0000000000000642","article-title":"Evaluation and construction of diagnostic criteria for inclusion body myositis","volume":"83","author":"Lloyd","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2022.12.001_bib0030","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.nmd.2013.07.007","article-title":"193rd ENMC International workshop pathology diagnosis of idiopathic inflammatory myopathies 30 November - 2 December 2012, Naarden, The Netherlands","volume":"23","author":"De Bleecker","year":"2013","journal-title":"Neuromuscul Disord NMD"},{"key":"10.1016\/j.nmd.2022.12.001_bib0031","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.nmd.2017.09.016","article-title":"Immune-Mediated Necrotizing Myopathies Working Group. 224th ENMC International Workshop:: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14-16 October 2016","volume":"28","author":"Allenbach","year":"2018","journal-title":"Neuromuscul Disord NMD"},{"key":"10.1016\/j.nmd.2022.12.001_bib0032","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3389\/fneur.2019.00554","article-title":"Biomarkers in Inflammatory Myopathies-An Expanded Definition","volume":"10","author":"Benveniste","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.nmd.2022.12.001_bib0033","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00401-021-02305-3","article-title":"Systemic sclerosis-associated myositis features minimal inflammation and characteristic capillary pathology","volume":"141","author":"Siegert","year":"2021","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.nmd.2022.12.001_bib0034","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s41927-021-00240-0","article-title":"Myositis with prominent B-cell aggregates causing shrinking lung syndrome in systemic lupus erythematosus: a case report","volume":"6","author":"Roy","year":"2022","journal-title":"BMC Rheumatol"},{"key":"10.1016\/j.nmd.2022.12.001_bib0035","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.nmd.2021.07.002","article-title":"A rare case of sporadic inclusion body myositis and rheumatoid arthritis exhibiting ectopic lymphoid follicle-like structures: a case report and literature review","volume":"31","author":"Konomatsu","year":"2021","journal-title":"Neuromuscul Disord NMD"},{"key":"10.1016\/j.nmd.2022.12.001_bib0036","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.autrev.2016.12.006","article-title":"Sj\u00f6gren's syndrome-associated myositis with germinal centre-like structures","volume":"16","author":"Espitia-Thibault","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.nmd.2022.12.001_bib0037","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/rheumatology\/keaa257","article-title":"Refining myositis associated with primary Sj\u00f6gren's syndrome: data from the prospective cohort ASSESS","volume":"60","author":"Felten","year":"2021","journal-title":"Rheumatol Oxf Engl"},{"issue":"1\u20132","key":"10.1016\/j.nmd.2022.12.001_bib0038","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jns.2010.02.015","article-title":"Dropped head syndrome as a presenting sign of scleromyositis","volume":"292","author":"Garcin","year":"2010","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nmd.2022.12.001_bib0039","doi-asserted-by":"crossref","first-page":"e694","DOI":"10.1212\/NXI.0000000000000694","article-title":"Thrombospondin-1 mediates muscle damage in brachio-cervical inflammatory myopathy and systemic sclerosis","volume":"7","author":"Su\u00e1rez-Calvet","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"10.1016\/j.nmd.2022.12.001_bib0040","doi-asserted-by":"crossref","first-page":"122","DOI":"10.4081\/reumatismo.2021.1397","article-title":"Brachio-cervical inflammatory myopathy associated with systemic sclerosis. Case series and review of literature","volume":"73","author":"Araujo","year":"2021","journal-title":"Reumatismo"},{"key":"10.1016\/j.nmd.2022.12.001_bib0041","doi-asserted-by":"crossref","first-page":"e1016","DOI":"10.1212\/NXI.0000000000001016","article-title":"Long-term follow-up and muscle imaging findings in brachio-cervical inflammatory myopathy","volume":"8","author":"Lucchini","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"10.1016\/j.nmd.2022.12.001_bib0042","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1002\/acr.22620","article-title":"Spectrum of muscle histopathologic findings in forty-two scleroderma patients with weakness","volume":"67","author":"Paik","year":"2015","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.nmd.2022.12.001_bib0043","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01952","article-title":"Tertiary lymphoid structures: autoimmunity goes local","volume":"9","author":"Pipi","year":"2018","journal-title":"Front Immunol."},{"key":"10.1016\/j.nmd.2022.12.001_bib0044","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00005-008-0014-5","article-title":"The role of B lymphocytes as antigen-presenting cells","volume":"56","author":"Chen","year":"2008","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10.1016\/j.nmd.2022.12.001_bib0045","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.jaci.2019.07.004","article-title":"B lymphocytes directly contribute to tissue fibrosis in patients with IgG4-related disease","volume":"145","author":"Della-Torre","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.nmd.2022.12.001_bib0046","first-page":"344","article-title":"Inclusion body myositis in association with rheumatoid arthritis","volume":"21","author":"Soden","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.nmd.2022.12.001_bib0047","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3899\/jrheum.141206","article-title":"Inclusion body myositis in a patient with RNA polymerase III antibody-positive systemic sclerosis","volume":"42","author":"Vemulapalli","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1016\/j.nmd.2022.12.001_bib0048","doi-asserted-by":"crossref","first-page":"92","DOI":"10.31138\/mjr.29.2.92","article-title":"Sj\u00f6gren Syndrome Associated with Inflammatory Muscle Diseases","volume":"29","author":"Migkos","year":"2018","journal-title":"Mediterr J Rheumatol"},{"key":"10.1016\/j.nmd.2022.12.001_bib0049","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2016-215035","article-title":"Efficacy of immunosuppressive treatment in a systemic lupus erythematosus patient presenting with inclusion body myositis","volume":"2016","author":"Varela-Rosario","year":"2016","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.nmd.2022.12.001_bib0050","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.nmd.2019.09.004","article-title":"A novel case of inclusion body myositis and myasthenia gravis","volume":"29","author":"Lambrianides","year":"2019","journal-title":"Neuromuscul Disord NMD"},{"key":"10.1016\/j.nmd.2022.12.001_bib0051","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/MD.0b013e31824d9cec","article-title":"Inflammatory myopathies with anti-Ku antibodies: a prognosis dependent on associated lung disease","volume":"91","author":"Rigolet","year":"2012","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.nmd.2022.12.001_bib0052","doi-asserted-by":"crossref","first-page":"e410","DOI":"10.1212\/NXI.0000000000000410","article-title":"Brachio-cervical inflammatory myopathy with associated scleroderma phenotype and lupus serology","volume":"5","author":"Gao","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"10.1016\/j.nmd.2022.12.001_bib0053","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.semarthrit.2019.11.008","article-title":"Concurrent anti-PM-Scl antibody-associated systemic sclerosis and inclusion body myositis - report of two cases and review of the literature","volume":"50","author":"Chatterjee","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.nmd.2022.12.001_bib0054","doi-asserted-by":"crossref","first-page":"e2068","DOI":"10.1212\/WNL.0000000000005638","article-title":"Muscular and extramuscular clinical features of patients with anti-PM\/Scl autoantibodies","volume":"90","author":"De Lorenzo","year":"2018","journal-title":"Neurology"},{"issue":"4\u20135","key":"10.1016\/j.nmd.2022.12.001_bib0055","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s10067-003-0715-4","article-title":"Inclusion body myositis in connective tissue disorders: case report and review of the literature","volume":"22","author":"Derk","year":"2003","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.nmd.2022.12.001_bib0056","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/nar\/gkr984","article-title":"Interferon gamma (IFN-\u03b3) disrupts energy expenditure and metabolic homeostasis by suppressing SIRT1 transcription","volume":"40","author":"Li","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.nmd.2022.12.001_bib0057","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/s41590-020-00814-z","article-title":"Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19","volume":"21","author":"Woodruff","year":"2020","journal-title":"Nat Immunol"},{"key":"10.1016\/j.nmd.2022.12.001_bib0058","doi-asserted-by":"crossref","first-page":"e451","DOI":"10.1212\/NXI.0000000000000451","article-title":"Architectural B-cell organization in skeletal muscle identifies subtypes of dermatomyositis","volume":"5","author":"Radke","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"10.1016\/j.nmd.2022.12.001_bib0059","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1212\/NXI.0000000000000019","article-title":"The lymphoid follicle variant of dermatomyositis","volume":"1","author":"Radke","year":"2014","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"10.1016\/j.nmd.2022.12.001_bib0060","doi-asserted-by":"crossref","first-page":"e535","DOI":"10.1212\/NXI.0000000000000535","article-title":"Inflammatory myopathy with myasthenia gravis: thymoma association and polymyositis pathology","volume":"6","author":"Uchio","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"10.1016\/j.nmd.2022.12.001_bib0061","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/2051-5960-1-29","article-title":"Comparative utility of LC3, p62 and TDP-43 immunohistochemistry in differentiation of inclusion body myositis from polymyositis and related inflammatory myopathies","volume":"1","author":"Hiniker","year":"2013","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.nmd.2022.12.001_bib0062","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/rheumatology\/kez406","article-title":"Identification of a novel autoantigen eukaryotic initiation factor 3 associated with polymyositis","volume":"59","author":"Betteridge","year":"2020","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.nmd.2022.12.001_bib0063","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1093\/rheumatology\/keaa801","article-title":"Polymyositis: is there anything left? A retrospective diagnostic review from a tertiary myositis centre","volume":"60","author":"Loarce-Martos","year":"2021","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.nmd.2022.12.001_bib0064","doi-asserted-by":"crossref","first-page":"e889","DOI":"10.1212\/WNL.0000000000008005","article-title":"Idiopathic inflammatory myopathy: Interrater variability in muscle biopsy reading","volume":"93","author":"Olivier","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2022.12.001_bib0065","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/jnen\/nlaa006","article-title":"Anti-HMGCR antibody-positive myopathy shows Bcl-2-positive inflammation and lymphocytic accumulations","volume":"79","author":"Kurashige","year":"2020","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.nmd.2022.12.001_bib0066","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00401-022-02438-z","article-title":"Skeletal muscle provides the immunological micro-milieu for specific plasma cells in anti-synthetase syndrome-associated myositis","volume":"144","author":"Preu\u00dfe","year":"2022","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.nmd.2022.12.001_bib0067","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s40425-019-0736-4","article-title":"Tertiary lymphoid organs in the inflammatory myopathy associated with PD-1 inhibitors","volume":"7","author":"Matsubara","year":"2019","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.nmd.2022.12.001_bib0068","doi-asserted-by":"crossref","first-page":"e985","DOI":"10.1212\/WNL.0000000000006124","article-title":"Immune checkpoint inhibitor-related myositis and myocarditis in patients with cancer","volume":"91","author":"Touat","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2022.12.001_bib0069","doi-asserted-by":"crossref","first-page":"e739","DOI":"10.1212\/WNL.0000000000013176","article-title":"Dermatomyositis: muscle pathology according to antibody subtypes","volume":"98","author":"Tanboon","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2022.12.001_bib0070","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/art.40063","article-title":"Editorial: a new classification of adult autoimmune myositis","volume":"69","author":"Sen\u00e9cal","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.nmd.2022.12.001_bib0071","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S1474-4422(18)30254-0","article-title":"Classification and management of adult inflammatory myopathies","volume":"17","author":"Selva-O'Callaghan","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nmd.2022.12.001_bib0072","doi-asserted-by":"crossref","first-page":"e12840","DOI":"10.1111\/nan.12840","article-title":"Capillary pathology with prominent basement membrane reduplication is the hallmark histopathological feature of scleromyositis","author":"Ellezam","year":"2022","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.nmd.2022.12.001_bib0073","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102498","article-title":"Muscle involvement in myasthenia gravis: expanding the clinical spectrum of Myasthenia-Myositis association from a large cohort of patients","volume":"19","author":"Garibaldi","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.nmd.2022.12.001_bib0074","article-title":"Muscle biopsy in myositis: what the rheumatologist needs to know","volume":"101763","author":"Merve","year":"2022","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.nmd.2022.12.001_bib0075","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00018-022-04388-x","article-title":"Role of tertiary lymphoid organs in the regulation of immune responses in the periphery","volume":"79","author":"Bery","year":"2022","journal-title":"Cell Mol Life Sci CMLS"},{"key":"10.1016\/j.nmd.2022.12.001_bib0076","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/s41591-022-01880-6","article-title":"The promise of precision medicine in rheumatology","volume":"28","author":"Guthridge","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.nmd.2022.12.001_bib0077","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0140-6736(20)32341-2","article-title":"Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial","volume":"397","author":"Humby","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.nmd.2022.12.001_bib0078","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.nmd.2015.02.014","article-title":"Myositis with endomysial cell invasion indicates inclusion body myositis even if other criteria are not fulfilled","volume":"25","author":"van de Vlekkert","year":"2015","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2022.12.001_bib0079","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1212\/WNL.0000000000004333","article-title":"Clinicopathologic features of myositis patients with CD8-MHC-1 complex pathology","volume":"89","author":"Ikenaga","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2022.12.001_bib0080","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000201506","article-title":"Inclusion body myositis: boundaries that may define transition to treatment refractoriness","author":"Greenberg","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2022.12.001_bib0081","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2018-000811","article-title":"Distinct interferon signatures stratify inflammatory and dysimmune myopathies","volume":"5","author":"Rigolet","year":"2019","journal-title":"RMD Open"},{"key":"10.1016\/j.nmd.2022.12.001_bib0082","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000201103","article-title":"Morphological and molecular patterns of polymyositis with mitochondrial pathology and inclusion body myositis","author":"Kleefeld","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2022.12.001_bib0083","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s40478-022-01389-6","article-title":"Inclusion body myositis and associated diseases: an argument for shared immune pathologies","volume":"10","author":"Nelke","year":"2022","journal-title":"Acta Neuropathol Commun"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896622007246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896622007246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:13:04Z","timestamp":1760775184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896622007246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":83,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S0960896622007246"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2022.12.001","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myositis with prominent B cell aggregates may meet classification criteria for sporadic inclusion body myositis","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2022.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}